oral semaglutide news HUGE in the GLP-1 space! Orforglipron has outperformed in the ACHIEVE-3 clinical trial in patients with type 2 diabetes. Comment your thoughts below! ⬇️ semaglutide oral cardiovascular indication 2025
Pay in 4 interest-free payments of $5.01 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7



























